More Business Wire
View Older Stories View Newer Stories-
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
-
Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2025
-
Dialogue AI Closes $6M Seed Round to Bring Live, AI-led Customer Research to Every Team
-
Petsense by Tractor Supply Continues 20Th Anniversary Celebration With Nationwide Fall Adoptathon
-
NEP Group Accelerates Growth and Innovation with New Funding and Successful Debt Refinancing
-
Providers Help U.S. Firms Bring Applications into AI Era
-
Extremis Systems Redefines Ballistic Protection With Innovative Female-Curved Valkyrie Body Armor
-
GE Appliances’ 2025 Blue Wave Mobilizes Nearly 1,000 Employee Volunteers to Uplift Communities Nationwide Setting a New Record of Engagement
-
Insperity Third Quarter Earnings Conference Call Monday, November 3
-
FanDuel Sportsbook is the 2025 American Gambling Awards Online Sportsbook of the Year
-
Infleqtion Leaders to Showcase Quantum Innovation at 2025 Q+AI Conference
-
26North Leads $700 Million Equity Investment in NEP Group to Accelerate Growth and Innovation
-
Fortune Brands Sets Date for Third Quarter Earnings Announcement and Investor Conference Call
-
Verily Launches a New Consumer Health App, Verily Me, at HLTH USA 2025
-
Qualcomm Announces Quarterly Cash Dividend
-
AM Best Affirms Credit Ratings of Luen Fung Hang Insurance Company Limited
-
Illumynt Reports Q3 2025 Business Update
-
The Bancorp, Inc. Sets Third Quarter 2025 Financial Results Release Date and Conference Call
-
Keysight Completes Acquisition of Synopsys’ Optical Solutions Group and Ansys’ PowerArtist
-
The Arena Group Acquires ShopHQ, Expanding into Data Syndication, E-Commerce and Social Selling
-
Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia
-
Marcus & Millichap, Inc. to Report Third Quarter 2025 Financial Results on Friday, November 7, 2025
-
IMFINZI® (durvalumab) regimen reduced the risk of disease recurrence or death by 32% in high-risk non-muscle-invasive bladder cancer in the POTOMAC Phase III trial
-
Savara Announces Chief Medical Officer (CMO) Transition
-
Butterfly Network to Report Third Quarter 2025 Financial Results on October 31, 2025
-
Samsung Electronics Completes Acquisition of Xealth, Accelerating Connected Care
-
ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025
-
Newegg Business Partners with Credit Key to Provide Flexible Financing Options, with Extended-Term Options Up to 12 Months
-
IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial
-
Franklin Templeton Closed-End Funds Announce Share Repurchases for the Third Quarter of 2025
-
Alliant Energy Corporation declares quarterly common stock dividend
-
29% of U.S. Home Purchases Are Made in Cash, Essentially Flat From a Year Ago
-
Republic Bancorp Reports a 12% Increase in Third Quarter Net Income
-
Actress Kate Hudson Brings Bold Personality and Glamour to Her Kitchen Remodel with CAFÉ™
-
Treasure Data Achieves the AWS Generative AI Competency
-
Clarion Partners Real Estate Income Fund Inc. Announces Results of Tender Offer
-
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
-
Cary Street Partners Strengthens Fiduciary Expertise in New Jersey
-
VENU Launches Its “Artist 280” Travel Services
-
StenTech Strengthens Precision Parts Platform with AME Acquisition
-
Oklo, newcleo Sign Strategic Partnership Alongside Blykalla for the Advancement of U.S. Nuclear Fuel Ecosystem
-
CatalYm Presents Phase 2 Data in Neoadjuvant Bladder Cancer Demonstrating Substantial Increase of Anti-Tumor Activity for Visugromab in Combination with PD-1 Inhibitor at ESMO
-
Agenus Reports 39% of Patients Alive at Two-Years with BOT/BAL Across Multiple Refractory Solid Tumors at ESMO 2025
-
REJUVENATION OPENS 13TH STORE NATIONWIDE IN SALT LAKE CITY
-
KBRA Releases Research – The Forward Look—European and UK Credit Views: Q4 2025
-
State Street Corporation (NYSE: STT) Reports Third-Quarter 2025 Financial Results
-
Expro Celebrates Success at the 2025 Gulf Energy Awards in Houston
-
Webster Reports Third Quarter 2025 EPS of $1.54
-
Jabil Declares Quarterly Dividend
-
Exchange Income Corporation Announces October 2025 Dividend
